We are live on ! Find out more
KALA icon

KALA BIO
KALA

28 hedge funds and large institutions have $12.8M invested in KALA BIO in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

843% more capital invested

Capital invested by funds: $1.36M → $12.8M (+$11.5M)

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

0.44% more ownership

Funds ownership: 0% → 0.44% (+0.44%)

47% less funds holding

Funds holding: 53 → 28 (-25)

81% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 31

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2.38M

Holders
28
Holders Change
-25
Holders Change %
-47.17%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
6
Closed
31
Calls
–
Puts
$2.38M
Net Calls
-$2.38M
Net Calls Change
-$2.38M

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$608K
2
Millennium Management
Millennium Management
New York
+$511K
3
CS
Clear Street
New York
+$391K
4
Jane Street
Jane Street
New York
+$205K
5
Bank of America
Bank of America
North Carolina
+$105K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$107K
2
VAFP
Vahanian & Associates Financial Planning
New York
-$46K
3
Citadel Advisors
Citadel Advisors
Florida
-$30K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20K
5
Northern Trust
Northern Trust
Illinois
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$2.93M +$608K +1,536 New
Millennium Management
2
Millennium Management
New York
$2.89M +$511K +1,291 +579%
CS
3
Clear Street
New York
$1.88M +$391K +988 New
Jane Street
4
Jane Street
New York
$990K +$205K +519 New
BlackRock
5
BlackRock
New York
$599K -$396 -1 -0.3%
Bank of America
6
Bank of America
North Carolina
$507K +$105K +264 +13,200%
SB
7
Samsara BioCapital
California
$459K – – –
BOTOTLSJU
8
Board of Trustees of The Leland Stanford Junior University
California
$434K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$404K +$14.6K +37 +21%
Vanguard Group
10
Vanguard Group
Pennsylvania
$389K -$107K -271 -57%
State Street
11
State Street
Massachusetts
$381K +$61K +154 +335%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$340K – – –
TSS
13
Two Sigma Securities
New York
$249K +$51.5K +130 New
KOCAA
14
Knights of Columbus Asset Advisors
Connecticut
$92.2K +$19K +48 New
Morgan Stanley
15
Morgan Stanley
New York
$79.9K +$396 +1 +2%
BCV
16
Banque Cantonale Vaudoise
Switzerland
$58K – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$25K +$4.75K +12 +1,200%
JP Morgan Chase
18
JP Morgan Chase
New York
$21K +$3.96K +10 +1,000%
Citigroup
19
Citigroup
New York
$18.1K +$1.58K +4 +67%
CLOS
20
Compagnie Lombard Odier SCmA
Switzerland
$15K – – –
UBS Group
21
UBS Group
Switzerland
$11.8K -$9.11K -23 -79%
Group One Trading
22
Group One Trading
Illinois
$11.6K – – –
Osaic Holdings
23
Osaic Holdings
Arizona
$9K – – –
MA
24
MCF Advisors
Kentucky
$8.77K +$1.98K +5 New
C
25
Covestor
United Kingdom
$8K -$396 -1 -20%
1
2 3

KALA Hedge Fund Activity: Q4 2022 in Review

28 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2022, worth a combined $12.8M — up 843% from $1.36M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of KALA and 6 opened new positions — a net loss of 25 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $608K. The largest seller was Vanguard Group, cutting an estimated $107K.

  • 28 institutional investors held KALA BIO (KALA) as of Q4 2022, down from 53 in Q3 2022.
  • Funds reported $12.8M of KALA BIO stock for Q4 2022, up 843% quarter-over-quarter.
  • 6 funds opened new KALA BIO positions in Q4 2022 and 31 closed out, a net change of -25 holders.
  • The largest KALA BIO buyer in Q4 2022 was Baker Bros. Advisors, an estimated $608K added.
  • The largest KALA BIO seller in Q4 2022 was Vanguard Group, an estimated $107K sold.

Based on aggregated 13F filings for Q4 2022.